This transcript has been edited for clarity. Lidia Schapira, MD: Hello. I'm Lidia Schapira, and I'm your host for this program, Medscape InDiscussion: Breast Cancer. Before I introduce this episode's ...

October 27, 2009 — Women with low- to intermediate-grade ductal carcinoma in situ (DCIS) with margins 3 mm or wider had an "acceptably low rate" of ipsilateral breast events 5 years after excision ...

DCIS, often called Stage Zero breast cancer, is the earliest stage and often diagnosed via mammogram, with no symptoms. In most cases, DCIS will not turn into a life-threatening tumor, but doctors ...

SAN ANTONIO -- Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer versus guideline-recommended treatment, the randomized COMET ...

Ductal carcinoma in situ (DCIS) of the breast develops into invasive breast cancer (IBC) in approximately 50 percent of women if left untreated, with the risk extending over more than forty years, ...

SAN ANTONIO – Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received ...

Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received upfront treatment, ...

Before breast screening with mammography became routine, ductal carcinoma in situ (DCIS) and high-risk breast lesions were rarely found. Now with the widespread use of mammography, those breast ...

A diagnosis of ductal carcinoma in situ (DCIS) might seem reassuring compared to invasive breast cancer, but recent research paints a more nuanced picture about this condition that affects roughly ...

Researchers at The University of Texas MD Anderson Cancer will share in a funding award of $13.4 million with hopes of answering one of the biggest questions in the current management of breast cancer ...